Predict your next investment

Venture Capital
tudorventures.com

See what CB Insights has to offer

Investments

149

Portfolio Exits

62

About Tudor Ventures

Tudor Ventures is the venture capital and private equity arm of Tudor Investment Corporation, an internationally recognized, $10 billion in assets, diversified investment management firm. Tudor has been investing in venture capital and other private equity opportunities since the early 1990's. Over this time, Tudor and its principals have invested in over 75 companies, and currently manage over $700 million in capital commitments.

Tudor Ventures Headquarter Location

50 Rowes Wharf 5th Floor

Boston, Massachusetts, 02110,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Tudor Ventures News

WestView Capital Partners Exits Investment in Thorne

Dec 7, 2018

WestView Capital Partners Exits Investment in Thorne Wednesday, October 10, 2018 New York, NY – Thorne today announced that WestView Capital Partners and Tudor Ventures have exited their investment in the Company as part of a recapitalization and joint strategic investment in the Company made by Mitsui & Co., Ltd. (Mitsui) and Kirin Holdings Company, Limited (Kirin). The joint investment between Kirin and Mitsui will be used to help expand Thorne’s personalized health technology platform and products and to jointly grow their businesses in Asia. This follows Mitsui’s investment in Thorne late last year. Thorne is a leading developer and manufacturer of high-quality, premium supplements sold primarily through medical professionals and also directly to consumers. For over 30 years, Thorne has been dedicated to enhancing the health and well-being of people worldwide by providing innovative, research-based nutritional supplements, personalized nutrition and technology-enabled medical education. Thorne is the only supplement manufacturer to collaborate with the Mayo Clinic on wellness research and content and is the proud partner of a number of U.S. National Teams, including U.S. Soccer, USA Hockey and USA Triathlon. “The Thorne team would like to thank WestView Capital Partners and Tudor Ventures for their support in helping us triple the size of the company during their tenure as investors, and we look forward to substantial growth in our new 270,000 square foot facility just outside Charleston, South Carolina, with Mitsui, Kirin and existing investor, Helsinn Group, as our investors going forward,” stated Paul Jacobson, Thorne’s CEO. “Paul and the Thorne team did a great job accelerating the growth of Thorne and realizing key strategic objectives including establishing partnerships with leading medical and wellness organizations,” said Rick Williams, a Managing Partner at WestView Capital Partners. “Their vision and commitment to the forefront of quality, efficacy and innovation in supplements have created an industry leading organization we are proud to have partnered with” added Williams. About Thorne Thorne is a leading developer and manufacturer of high-quality, premium supplements. For over 30 years, Thorne has been dedicated to enhancing the health and well-being of people worldwide by providing innovative, research-based nutritional supplements, personalized nutrition and technology-enabled medical education. Thorne is the only supplement manufacturer to collaborate with the Mayo Clinic on wellness research and content and is the proud partner of a number of U.S. National Teams, including U.S. Soccer, USA Hockey and USA Triathlon. Thorne is one of the fastest growing supplement companies and is rated the top practitioner-dispensed brand among 30 to 40 year-olds. For more information visit www.thorne.com. About WestView Capital Partners WestView Capital Partners, a Boston-based private equity firm focused exclusively on middle market growth companies, manages approximately $1.7 billion in capital across four funds. WestView partners with existing management teams to sponsor minority and majority recapitalizations, growth, and consolidation transactions in industries such as growth industrial, business services, software and IT services, healthcare technology and outsourcing, and consumer. WestView invests in companies with operating profits between $3 million and $25 million with investment sizes ranging from $15 million to $60 million. For more information, please visit www.wvcapital.com.

Tudor Ventures Investments

149 Investments

Tudor Ventures has made 149 investments. Their latest investment was in Vix as part of their Series H on June 6, 2019.

CBI Logo

Tudor Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/30/2019

Series H

Vix

$18.7M

No

1

4/8/2014

Series C

NetProspex

$13M

Yes

4

4/2/2014

Series A

One Door

$9.5M

Yes

1

3/27/2013

Debt

Subscribe to see more

$99M

Subscribe to see more

0

12/18/2012

Series D

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/30/2019

4/8/2014

4/2/2014

3/27/2013

12/18/2012

Round

Series H

Series C

Series A

Debt

Series D

Company

Vix

NetProspex

One Door

Subscribe to see more

Subscribe to see more

Amount

$18.7M

$13M

$9.5M

$99M

$99M

New?

No

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

4

1

0

10

Tudor Ventures Portfolio Exits

62 Portfolio Exits

Tudor Ventures has 62 portfolio exits. Their latest portfolio exit was Thorne HealthTech on September 23, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

9/23/2021

IPO

$99M

Public

4

2/1/2021

Acquired - II

$99M

8

1/28/2020

Asset Sale

$99M

1

9/9/2019

Acq - Fin

Subscribe to see more

$99M

Subscribe to see more

10

7/22/2019

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/23/2021

2/1/2021

1/28/2020

9/9/2019

7/22/2019

Exit

IPO

Acquired - II

Asset Sale

Acq - Fin

IPO

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

4

8

1

10

10

Tudor Ventures Acquisitions

3 Acquisitions

Tudor Ventures acquired 3 companies. Their latest acquisition was TractManager on July 13, 2007.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

7/13/2007

$99M

Acquired

8/9/2006

Subscribe to see more

$99M

Subscribe to see more

0

5/5/2006

Series B

Subscribe to see more

$99M

$99M

Subscribe to see more

0

Date

7/13/2007

8/9/2006

5/5/2006

Investment Stage

Series B

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Total Funding

$99M

Note

Acquired

Subscribe to see more

Subscribe to see more

Sources

0

0

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.